Morgan Stanley Sensus Healthcare, Inc. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Morgan Stanley holds 185,268 shares of SRTS stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
185,268
Previous 36,240
411.23%
Holding current value
$1.33 Million
Previous $193,000
456.48%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SRTS
# of Institutions
55Shares Held
3.89MCall Options Held
24.9KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA779KShares$5.59 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny409KShares$2.93 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA304KShares$2.18 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX290KShares$2.08 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY154KShares$1.1 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $119M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...